Prebiotic galacto-oligosaccharide supplementation of the low FODMAP diet in irritable bowel syndrome: a randomised controlled trial
Wilson B, Rossi M, Kanno T, Parkes GC, Anderson S, Mason AJ, Irving PM, Lomer MC, Whelan K
Published in American Journal of Gastroenterology
Methodology
Four-week randomised placebo-controlled trial of B-GOS alongside the low FODMAP diet in patients with IBS
Key Findings
The low FODMAP diet improved symptoms, but co-administered GOS neither added symptom benefit nor prevented the diet-induced decline in bifidobacteria.
Conclusions
GOS did not rescue bifidobacteria or improve symptoms beyond the low FODMAP diet alone.
Limitations
Short duration; complex dietary co-intervention.
Supplements Studied
Co-administered galacto-oligosaccharides did not improve symptoms beyond the low FODMAP diet nor prevent the diet-induced decline in bifidobacteria.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.